Concepedia

Jolien S. de Groot

JS

Statistics

Publications

10

Citations

370

H-Index

10

Active since

2013

Affiliations

University Medical Center Utrecht(Current)

Utrecht University

The Netherlands Cancer Institute

University of Cambridge

Medicines Evaluation Board

Jolien S. de Groot is an author at University Medical Center Utrecht specializing in oncology, medicine, and molecular oncology.

Publications per year

2013–2024

10

Publications

10

Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials

Rik J. Verheijden, Jolien S. de Groot, Babs O. Fabriek et al. · Journal of Clinical Oncology · 2024 · 93 citations · Full text

, , +17

αE‐catenin is a candidate tumor suppressor for the development of E‐cadherin‐expressing lobular‐type breast cancer

Jolien S. de Groot, Max A. K. Rätze, Miranda van Amersfoort et al. · The Journal of Pathology · 2018 · 51 citations · Full text

, , +16

p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis

Robert A. H. van de Ven, Jolien S. de Groot, Danielle Park et al. · Nature Communications · 2016 · 49 citations · Full text

, , +15

Validation of DNA promoter hypermethylation biomarkers in breast cancer — a short report

Jolien S. de Groot, Xiaojuan Pan, Jan Meeldijk et al. · Cellular Oncology · 2014 · 47 citations · Full text

, , +16

DNA promoter hypermethylation in nipple fluid: a potential tool for early breast cancer detection

Jolien S. de Groot, Cathy B. Moelans, Sjoerd G. Elias et al. · Oncotarget · 2016 · 33 citations · Full text

, , +14

1–5 of 10